Background: Regional-dwelling adults have higher levels of cardiovascular disease (CVD) risk. Aims: To determine the potential benefits of a nurse-led, self-management intervention program to reduce CVD and diabetes risk.
Introduction
People living in regional, rural or remote locations consistently fare worse than their metropolitan counterparts in respect to cardiovascular risk and outcomes. [1] [2] [3] Within the widely dispersed and heterogeneous Australian population, mortality rates rise in accord with greater remoteness, 4 and regional dwelling Australians are more likely to die from coronary artery disease (44%) or stroke (31%) than those living in major cities, 5 with even greater differentials for fatal hypertensive heart disease (90% more likely) and heart failure (70% more likely) events. Regional Australians have been found to have high levels of antecedent risk for cardiovascular disease (CVD) that are disproportionate to metropolitan dwelling adults. 3, 6, 7 These challenges have also been recognized in Europe, 8 North America, 9 Asia 10 and South Africa. 11 Despite this, specialist cardiac services are scarce, few cardiologists practice in non-metropolitan areas 5 and there are less primary physicians per population; 12 the latter being particularly significant given that regional primary care clinics absorb a greater burden of health care than metropolitan clinics experience. Consistent with these data, the Healthy Hearts Beyond City Limits program 13 found high levels of risk and a need for more pro-active prevention in regional communities.
Large amounts of health care expenditure are predominantly directed towards CVD 14 which has been of some value in reducing CVD-related mortality. 4 Yet this allocation of funds is largely reactive and absorbed by hospital care and pharmaceutical treatment costs, rather than supporting pro-active detection and prevention of CVD. Implementation of nurse-led management programs is potentially cost-effective in achieving positive health outcomes (from reducing risk levels to minimizing recurrent hospital stay and prolonging survival) from a primary prevention, 15 secondary prevention, 16 and chronic disease management perspective. 17 However given the heterogeneity of health care systems, their reimbursement mechanisms, and specific needs of target individuals and communities, it is critical to robustly develop and test models of care before wider implementation. The aim of the Protecting Healthy Hearts study was to evaluate the potential benefits of a nurse-led, self-management intervention program to optimize risk factor profiles for CVD and diabetes prevention in a high risk and under-serviced population of regional-dwelling Australians.
Methods

Study setting
Protecting Healthy Hearts was a six-month, pre-and postobservation, intervention study. A cross-sectional observational study of antecedent risk for CVD and related lifestyle factors 13 was previously carried out in four regional locations to identify the community most likely to benefit from a pro-active prevention program. The Protecting Healthy Hearts program was conducted from September 2009-May 2010 in Colac (adult population of 7172 and 152 km south-west of Melbourne, Victoria, Australia). A full-time clinic was established at an address adjacent to the local hospital with clear signage and identification. The study was approved by the Alfred Ethics Committee, Melbourne (Project No. 71/07).
Design
The program methodology comprised a self-administered questionnaire, non-invasive clinical measurements and risk assessment to provide a tailored program of multifactorial intervention and follow-up over six months. Individualized self-care and management plans were developed for those assessed as at high risk of, or having poorly managed, CVD and/or diabetes, according to the GARDIAN (Green Amber Red Delineation of rIsk And Need) management system. 18 In brief, a red code ("act now" to address risk) was assigned to individuals with extreme risk indicator(s) or an estimated CVD risk score ≥16%. As shown in Figure 1 , the follow up strategy for red-coded individuals involved remote (telephone/email) support with a diabetes educator or cardiac nurse at one month and clinic visits at three months (to tailor the management plan) and six months. An amber code (proceed with caution ensuring that risk factors are addressed in the short term) was assigned to people with at least two suboptimal risk factors (e.g. hypertension, hyperlipidemia, hyperglycemia, obesity or smoking) or an estimated CVD risk score of 10-15%. The follow up strategy for ambercoded individuals involved remote consultation at one month and clinic follow-up at six months. A green code (continue as usual and endeavor to improve risk factors) was assigned to individuals with one or no risk factors or an estimated CVD risk score of 9% or less. All greencoded individuals were followed up after six months to assess change. Appointments were half-hourly with a capacity of 15 people per day. Health checks and accompanying feedback and advice were performed by specially trained registered nurses and/or a diabetes educator. Core technical and clinical training via face-to-face meetings Intervention Response Rates: was provided to staff to deliver the program according to a standardized protocol. Processes for maintaining competencies included regular appraisal of the nurse/patient encounters and an independent review, by a senior investigator, of the self-care and management plans.
Sample
The program used a self-selected cohort of the adult population aged over 18 years who responded to local newspaper(s) and radio station advertisements for a free health check. They had to be able to give written consent to participate. Overall, 530 individuals volunteered to participate, representing 7% of the adult population (based on place of usual residence). 19 
Study data
The data collection schedule was very similar to our previous study described in greater detail elsewhere. 13 The selfadministered questionnaire included questions about socio-demographic background, diet (saturated fat) 20 and lifestyle habits, personal and family medical history; pharmacotherapy, symptoms (physical and mental) and health related quality of life (Short-Form SF-12v2). 21 In addition, and in accord with the self-management intervention program, a modified self-care index was incorporated 22 (by administering Sections A and C only with reference to risk factors and health advice for CVD rather than heart failure symptoms and treatment) for evaluation of self-care practices. In the clinical assessments, blood pressure (BP), height, weight, waist and hip circumference, lipid and glucose profiling, electrocardiography (ECG) and spirometry were measured in accordance with manufacturer instructions and nationally recommended protocols. BP was measured using the Omron HEM-907 (Omron Healthcare Co. Ltd, Kyoto, Japan) digital automatic BP monitor. Blood lipid and glucose levels were analyzed using the CardioChek PA (Polymer Technology Systems Inc., Indiana, USA) analyzer. All other instrumentation and procedures including a description of the risk factor definitions are comprehensively described elsewhere. 13 Written summary reports identifying optimal and sub-optimal CVD/diabetes risk factors (according to relevant national guidelines) and estimated CVD and type 2 diabetes risk via the Australian type 2 diabetes risk assessment tool (AUSDRISK) were produced for each participant. Basic health education was discussed with all participants by a nurse and/or diabetes educator.
Tailored intervention
The remainder of the assessment involved a more in-depth nurse consultation for GARDIAN-designated amber and red subjects to develop individualized self-care and management plans where appropriate. The emphasis of the intervention was to induce self-initiated behavioral change (with nurse support) to promote a healthier diet and lifestyle plan, enhance therapeutic adherence to medications and develop self-care abilities. Key elements of the participant/nurse encounter entailed a:
1. Review of behavioral, biomedical and familial risk factor results in contrast to recommended levels from published guidelines and reports 2. Establishment of goals and priority areas to address gaps in ideal risk indicators, with due consideration of obstacles or catalysts in tackling them 3. Development of an agreed care plan with attainable targets and clear communication of how to achieve them that was facilitated by user friendly educational brochures 4. Identification of appropriate community lifestyle programs that were located from a thorough audit previously undertaken in the region 5. Recommendation for medical or allied health professional referral (e.g. dietician) for treatment or improved pharmacological management 6. Scheduled follow-up at a frequency commensurate with risk and need to reinforce positive changes and assist participants to achieve their goals 7. Provision for regular communication with a diabetes educator or cardiac nurse 8. Reconsideration of agreed care plan to tailor management and adjust priority areas (red group only).
Data analyses
Normally distributed continuous data are presented as the mean±standard deviation (SD). Categorical data are presented by count and percentages. Student's t-tests were used to assess baseline sex differences for continuous variables with consideration to Levene's Test for Equality of Variances to correct for violations of homogeneity of variance. Discrete variables were analysed via odds ratios (ORs) with 95% confidence intervals (CIs) or χ 2 analysis. No significant sex differences in outcome measures for participants who completed the final follow-up were found. Hence, paired t-tests were used to assess the effect of the intervention from baseline to six months. To consider the confounding effect of non-completers, we carried forward the last recorded clinical results in sensitivity analyses of the impact of the intervention. Backwards stepwise binomial logistic regression analyses were performed on biological (age, sex), socio-demographic (marital status, ethnicity, education), diet and lifestyle (fruit, vegetable and saturated fat intake, physical activity), clinical (depression, personal or family history of CVD or diabetes) and interventional factors (GARDIAN status, formal care plan, counselling, primary physician attendance, treatment for anti-hypertension or lipid modification) to derive adjusted ORs for the likelihood estimates of the relative change in BP (≥10% systolic and/or ≥5% diastolic BP from baseline to six months), total cholesterol (≥10%), weight (≥5%) and absolute change in CVD risk scores (≥1%). Significance was accepted at the twosided level of 0.05. Data were analysed using SPSS Statistics 19.0.
Results
Study cohort
The socio-demographic and baseline risk factor profile of participants is shown in Table 1 . Subjects were predominantly middle-aged (54±14 years) and Caucasian with more female participants overall (62%). Women were less likely to be married/living with a partner and their education and employment profiles differed significantly from men.
Baseline risk profiles
Modifiable risk factors were highly prevalent. Overall, 74% were physically inactive, 67% had abdominal obesity, 42% were hypertensive and 37% had elevated low density lipoprotein (LDL) cholesterol (Table 1) . Women were significantly less likely than men to have hypertension, reduced high density lipoprotein (HDL) cholesterol, excess alcohol consumption or a major ECG abnormality. Alternatively, women were significantly more likely to have elevated total cholesterol and be less physically active. There was a tendency for women to be at low absolute CVD risk and AUSDRISK (with fewer than expected cases at moderate or high risk) and men to be at moderate and high absolute CVD risk and AUSDRISK (with less at low risk). There were no other significant gender differences for any risk factor.
Management and investigations
According to our GARDIAN criteria, 231 (43%), 178 (34%) and 121 (23%) participants were assessed as requiring low (green), moderate (amber) or high (red) levels of surveillance and management, respectively ( Figure 1 ). Priority areas to address gaps between actual and ideal risk indicators included dietary advice (n=290, 55%), physical inactivity (n=225, 43%), weight loss (n=213, 40%), improved treatment adherence and knowledge (n=46, 9%), smoking cessation (n=27, 5%) and holistic advice (n=19, 4%). Formal care plans were developed for 281 (53%) participants with referral to a fitness program/gym (n=22, 4%), smoking cessation program (n=13, 3%) or healthy eating class (n=8, 2%) for some. In response, Figure 1 shows that the cardiac nurses followed up a total of 248 amber and red-coded participants after one month to reinforce positive changes and assist them to achieve their goals via email (n=57, 11%) or telephone coaching (n=191, 36%) for an average call duration of 3.5 min. As per protocol, 90 (74%) red-coded individuals attended a three-month clinic visit. According to the baseline risk audit, 62 (12%) individuals were recommended for prompt review by a primary physician for extreme risk indicators.
Impact of the intervention
Early effects (high risk (red) individuals only). After three months, statistically significant improvements in higher risk (red) participant's mean risk factor levels became evident. There were early reductions in systolic BP of 5 mm Hg, weight (1.1 kg), body mass index (BMI) (0.5 kg/m 2 ), waist circumference (1.5 cm) and total (0.43 mmol/l) and LDL cholesterol (0.32 mmol/l), all p<0.1.
Change in risk factors and interventional recommendations (six-month follow-up).
Of 530 participants, 435 (82%) attended both baseline and final (six-month) clinic visits.
Overall, we observed individual improvements in most outcome measures over six months. Table 2 shows that half to two-thirds of all participants had better levels of the majority of risk factors, with the most gains in blood glucose (64% benefited), lipids (76%, triglyceride to 67%, LDL cholesterol) and weight (61%) modification. Many participants improved dietary saturated fat (60%) and physical activity measures (54%). HDL cholesterol levels remained unchanged or worsened (decreased) for numerous people (70%) whereas psychometric variables improved for approximately half of individuals. When average changes in outcome measures were considered, Figure 2 and Table 2 show that BP significantly decreased by 4/1 mm Hg, weight by almost 1 kg and BMI by 0.3 kg/m 2 . During study follow-up, lipid profiles significantly improved with decreased levels of total cholesterol (from 4.75 to 4.13 mmol/l), LDL cholesterol (from 2.68 to 2.37 mmol/l) and triglyceride (from 1.59 to 1.22 mmol/l). Reaffirming these improvements in those with a six-month follow-up visit, a mean change in absolute CVD risk scores of -0.4% was observed. Similarly, mean glucose levels declined from baseline to six months (5.19 vs 4.63 mmol/l). Alternatively, HDL cholesterol levels declined from 1.42 to 1.29 mmol/l over the same time period; whilst remaining within recommended limits. In support of observed improvements, Table 2 shows that dietary saturated fat intake decreased, yet there were nominal changes in fruit and vegetable intake and physical activity (all p>0.05). Psychometric measures showed a small improvement in mental health scores but not physical health scores derived from the SF-12v2 21 and participants increased self-care maintenance behaviors but there was no significant change in confidence in self-care according to a modified self-care index. Figure 2 shows that there were more red-coded individuals who did not attend the six-month follow up visit (23% red vs 17% amber vs 16% green). We carried forward the last measurements at three months from 10 redcoded individuals and at baseline from 36, 31 and 18 green, amber and red-coded participants, respectively. In sensitivity analyses incorporating those who did not complete the program, there remained to be statistically significant improvements to BP, weight, BMI, waist circumference, total and LDL cholesterol, triglyceride and glucose, with a reduction to HDL cholesterol (all p<0.01).
Primary physician follow-up. A total of 141 (32%) participants who returned for a final six-month follow-up had visited their primary physician which resulted in initiation/ modification of pharmacological treatment, further investigations or healthy dietary/lifestyle advice in 24 (6%), 18 (4%) and 36 (8%) participants, respectively. Accordingly, we became aware of four new cases each of atrial fibrillation, stroke and cancer and one case each of heart failure and depression. Therapy was started/altered for anti-hypertension (14 cases), lipid modification (eight cases), anti-arrhythmias (two cases), anti-coagulation (four cases), diabetes (one case) and depression (two cases). BP fell from 150/82 mm Hg at baseline to 141/79 mm Hg at completion of the study after initiation or change of treatment class or dose. Likewise, total cholesterol decreased from 5.36 to 3.69 mmol/l and LDL cholesterol from 3.26 to 1.89 mmol/l (n=5) between baseline and six months, subsequent to starting lipid-modifying therapy.
Determinants of change
Overall, we observed clinically significant changes (of a sufficient magnitude as per our prospectively applied criteria) in 326 (76%) participants, comprising reductions in BP (n=184, 42%), total cholesterol (n=252, 59%), weight (n=44, 10%) and absolute CVD risk (n=131, 45%). After adjustment for potential confounders, statistically significant improvements in BP were more likely for people who attended their primary physician during the study follow-up period (OR 
Discussion
The Protecting Healthy Hearts study provides strong evidence for the benefits of a nurse-led, regional risk surveillance and intervention clinic. As expected, we observed high levels of risk for CVD and diabetes among study participants. Subsequent risk factor modification via the study intervention resulted in clinically significant pre and post measured improvements for the majority of participants (76%). Nurse management, guided by the previously described GARDIAN system designed to focus care and health resources to those most in need, 18 proved to be an effective approach to initiate improvements from an individual perspective for at least half of participants in many outcome measures, with the greatest gains in lipid and weight modification achieved largely via reductions in dietary saturated fat. Additionally, a moderate level of engagement with primary physicians contributed to improved risk factor management facilitated by pharmacological therapy. In adjusted analyses, primary physician attendance was particularly important for improving BP outcomes. GARDIAN status, age, physical activity and nurse guidance (including diabetes educators) were also independent correlates of clinically significant reductions in risk factors.
Our results reconfirm highly prevalent risk factors for CVD and diabetes in regional adults. Over a quarter of participants were obese and two thirds had abdominal obesity, around one-third did not meet recommended targets for either total or LDL cholesterol, hypertension affected two in five participants and three-quarters of participants were not undertaking sufficient physical activity. These findings are similar to the most recent population estimates from the Australian Health Survey 24 where the proportion of adults not meeting recommended levels was 33% for total and LDL cholesterol, 27.5% for obesity and 21.5% for BP≥140/90 mm Hg (excluding those with controlled BP and taking antihypertensive therapy). However our results from a regional location, whereby CVD morbidity and antecedent risk is higher than metropolitan locations, 3, 5 remain higher than those reported in state-wide and local survey data for the adult population. 2 This could well reflect the self-selected nature of participants seeking assistance to reduce elevated risk levels (the overarching goal of the program). As such, this was a predominantly middle-aged cohort. Moreover, we applied potentially different methods and levels of risk to profile the study cohort. For example, sufficient physical activity can be defined by duration alone (minutes per week) or including a frequency (sessions per week) component. Nevertheless, the findings confirmed there was large potential for risk factor modification via an intervention program.
There was evidence that our intervention had positive effects on physiological factors and participants were able to make comprehensive lifestyle changes to reduce CVD and diabetes risk. Of all subjects who attended a six-month follow up visit, the absolute change in systolic BP was -4 mm Hg and diastolic BP -1.3 mm Hg, weight reduction was -0.8 kg and mean lipid changes were -0.6 mmol/l for total cholesterol, -0.3 mmol/l for LDL cholesterol and -0.4 mmol/l for triglyceride. In a meta-analysis of 42 studies, 25 multi-factorial lifestyle interventions in primary prevention reduced systolic BP by -3.0 mm Hg, diastolic BP by -4.2 mm Hg, total cholesterol by -0.36 mmol/l and weight by -0.9 kg. Our intervention program achieved similar results among community participants, albeit better for some risk factors, although greater improvements have been found with more rigorous interventions over longer follow-up periods in higher risk individuals [26] [27] [28] [29] and using enhanced pharmacological management. 30, 31 The lasting effects beyond the program completion are uncertain however and short-term clinically significant positive adjustments may not be sustained over the longer term 32 or indeed translate into reduced CVD morbidity and mortality 33 because of gradual degradation in risk factor profile after initial improvements are made reflecting lack of permanence in healthy lifestyle behavioral change.
Reduced dietary saturated fats appeared to have beneficially altered risk factor levels, albeit for HDL cholesterol which decreased significantly. This counterproductive finding has been previously observed 34 and occurred in the present study independent of modifications to HDL cholesterol (i.e. reduced saturated fats were shown for participants whose HDL cholesterol improved, worsened, or remained unchanged) which was not counteracted by increased physical activity (data not shown). The influence of dietary changes on the total cholesterol to HDL cholesterol ratio as part of the Framingham risk equation 35 may have led to a seemingly small or moderate effect of-0.4% to calculated absolute CVD risk scores compared to other studies. 27 Our observed reduction in five-year CVD risk and the clinical value of lifestyle interventions 36, 37 and drug treatment remains obvious 30, 31 and together should have notable individual 38 and public health benefit. Pending confirmation via a prospective randomized trial examining the definitive cost-benefits of this type of intervention (with further confirmation of longer-term changes in health behaviors and risk), the number needed to treat to avoid merely one highly costly cardiovascular event is likely to be between 150-200 individuals. This number could be as low as 100 if augmented by a more efficient use of the GARDIAN system to direct care and support where it is most needed and enhanced with more aggressive pharmacotherapy to further reduce risk levels in higher risk individuals.
An amalgamation of factors unique to the intervention, targeting healthier dietary and lifestyle changes, enhanced medication adherence, education, and self-care abilities, were considered fundamental in yielding favorable outcomes in risk factor reduction. Receipt of a computerized written report of risk profiles, 39 educational print material and brief standard advice relative to recommended guidelines and individualized results reinforced the basics about optimal cardiovascular health and may have helped subjects become aware of the need for improvement in their cardiovascular risk. Testament to this was the increase in self-care (maintenance) behaviors deemed to be important in living a healthy lifestyle and adhering to treatment regimens. 22 For higher risk amber-and red-designated individuals, encouragement in self-monitoring, telephone/email reinforcement and mutually agreed-upon health care plans through shared decision making appeared to have merits and potentially empowered participants to reach their desired outcomes. Specific behavioral goals (e.g. restriction of processed meats) instead of physiological targets (e.g. 10% reduction in total cholesterol) may have also facilitated participant-led changes to reach agreed health targets. The GARDIAN system, delivered by nurses themself and encompassing all of these components, promoted behavioral change by varying (by degree of risk and need) scheduled follow-up to monitor progress and provide ongoing feedback on goal attainment. The individualized, systematic strategy of GARDIAN, encapsulating many of the evidence-based recommendations for dietary and lifestyle intervention 32 and including escalation for professional medical referral, was shown to be an independent predictor of improvements in risk factors for CVD and diabetes. This system however needs to be investigated across a range of other settings from different parts of the world in order to examine its true effectiveness.
A number of study limitations require comment. Firstly, we examined the impact of the study intervention using a non-randomized, pre-and post-follow-up design. This method tends to over-estimate any observed changes relative to a true control group; an appropriately powered randomized controlled study based on our initial positive observations and incorporating enhanced use of telehealth support is planned. To address the issue of measurement bias in those willing to complete six-month follow-up, we performed sensitivity analyses based on the assumption of no change in non-completers to confirm the robustness of our findings. As a self-selected cohort from one regional community (considering the importance of ethnic, socioeconomic and environment factors unique to each community) our positive overall findings cannot be readily generalized without caution. Whether positive changes in healthy lifestyle behaviors will persist beyond six months is unknown. However, the potential impact of any new service (such as regional, nurse-led risk clinics) to address persistently high levels of antecedent risk for CVD in regional communities is perhaps incontrovertible.
These results support an optimal approach for identifying and managing high-risk candidates for the prevention of CVD and diabetes in regional Australian communities. Our intervention, a nurse-led risk clinic with community support, showed a positive effect in approximately threequarters of individuals who participated in the program. Moreover, the application of the GARDIAN traffic light assessment and management tool was able to appropriately direct care and support on an individual-basis. If confirmed, these data provide a strong basis for establishing a network of clinics, ensuring there is a connection between cost and benefit, to apply this intervention throughout regional Australia to support efforts to reduce future cardiovascular-related morbidity and mortality in many high risk individuals and communities.
Implications for practice
• • Nurse-facilitated clinics are advantageous for managing cardiovascular disease risk. • • Guidance via the GARDIAN system facilitates risk factor reduction. • • Health professional contacts are reserved for managing higher risk individuals. • • A network of nurse-led clinics to apply the intervention is a priority to combat cardiovascular disease.
